Articles: function.
-
Pulmonary Vascular Disease CasesSESSION TYPE: Case ReportsPRESENTED ON: Saturday, March 22, 2014 at 04:15 PM - 05:15 PMINTRODUCTION: Thromboembolic events including pulmonary embolism (PE) are known to occur in association with advanced stages of lung cancer. Known cancer is a risk factor for development of venous thromboembolism, including PE. However, when a patient without known cancer presents with acute PE, cancer as a potential cause of PE may not always be explored. We present a case of acute PE, later found to have adenocarcinoma of lung with metastasis. ⋯ The following authors have nothing to disclose: Viral Patel, Abhay Vakil, Mehul Rooparelia, Kelly Cervellione, Samir SarkarNo Product/Research Disclosure Information.
-
COPD Epidemiology & Physiology PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Common techniques used to measure lung volumes may yield inaccurate results in patients with large bullae. Plethysmography may overestimate while gas dilution may underestimate functional lung volumes. Auto Smart Segmentation (SS) is used by radiation physicists to accurately map lung portions receiving radiation therapy. It uses contouring methodology to trace and accurately measure volume of contoured anatomic structures. Hypothesis. Contouring of bullae on thoracic Computed Tomography (CT) and digital subtraction of contoured volumes using SS will yield accurate lung volumes unaffected by technical limitations or patient effort. ⋯ The following authors have nothing to disclose: Basim Dubaybo, Sikandar AnsariNo Product/Research Disclosure Information.
-
Critical Care Posters IIISESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: We previously demonstrated in a clinically relevant murine model of sepsis, that animals with left ventricular (LV) dilation had better cardiovascular performance and increased survival. Using the same model of sepsis, we sought to determine if survivors have an early phenotype different from non-survivors with different resuscitation regiment. ⋯ The following authors have nothing to disclose: François Dépret, Fabien Picard, Sergio Zanotti-Cavazzoni, Steven HollenbergNo Product/Research Disclosure Information.
-
Lung Ventilation/Perfusion Scan With SPECT-CT on Two Patients With Congenital Thoracic Malformation.
Congenital Disorder Case Report PostersSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Poland syndrome was first describe by Alfred Poland in 1941, as the presence of syndactyly and the partial or complete absence of ipsilateral chest muscle, although is more common to find absence on its sternocostal portion, with or without absence of the minor pectoral. Pectus excavatum is a congenital deformity of the anterior wall of the thorax, in which the costal cartilages grow abnormally. In previous studies the quantitative evaluation of the lung volume has been reported with scintigraphy with the SPECT-CT technique with 99m Tc macroaggregates formulation, having as a goal to determine the favorable changes of the surgical reconstruction by Thoracoscopy assisted NUSS procedure on patients with pectus excavatum. After the bibliographic review, there were no reports found for the lung function evaluation by the SPECT-CT technique on any thoracic malformation. ⋯ Is expected to provide, beside the morphological evaluation by conventional imaging tests, a functional technique with nuclear medicine by the lung ventilation/ perfusion scan with SPECT-CT technique to determine the lung function and changes of the secondary lung parenchymal to congenital alterations of the thoracic cage, keep monitoring and reevaluate the lung function after surgical treatment.Reference #1: Pearl, Pediatric Radiology Poland Syndrome 1971;101:619-62 2. Pinedo Presentación de un caso de corrección cosmética de pectus excavatum Rev INER 2005;18:117-122 3. Mansour Ann Thorac Surg 2003;76:391-395 4. Protopapas, Journal of Cardiothoracic Surgery 2008,3:40 5. Onur, Ann Saudi Med 2006;26(5):370-374 6. Schanberger, General Thoracic Surgery, 2005 6th ed, Chapter 41DISCLOSURE: The following authors have nothing to disclose: Sigelinda Sandoval Borrego, Francina BolanosI agree.
-
Cardiovascular Case Report Posters IISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Carfilzomib is a novel chemotherapy agent for the treatment of relapsed and refractory Multiple Myeloma (MM). It is a selective, irreversible proteasome inhibitor that induces apoptosis of myeloma cells. It was approved by US-FDA in July 2012. ⋯ The following authors have nothing to disclose: Sameer Chadha, Rahul Yadav, Kunal Teli, Guy Kulbak, Gerald Hollander, Jacob ShaniNo Product/Research Disclosure Information.